Living donor liver transplants for sick recipients during COVID-19 pandemic-An experience from a tertiary center in India
| Autor: | Shaleen Agarwal, Rajesh Dey, Vivek Yadav, Bansidhar Tarai, Sharat Varma, Subhash Gupta, Vijaykant Pandey, Dibyajyoti Das, Kaushal Madan, Bhargav R. Chikkala, Shekhar Singh, Sapana Verma, Sumit Goyal, Vaibhav Nasa, Singh Shweta |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Tissue and Organ Procurement Adolescent medicine.medical_treatment India Comorbidity Liver transplantation Malignancy Young Adult Pandemic medicine Living Donors Immunology and Allergy Humans Pharmacology (medical) Decompensation Young adult Child Pandemics Letter to the Editor Transplantation business.industry SARS-CoV-2 Outbreak COVID-19 Infant Middle Aged medicine.disease Transplant Recipients Liver Transplantation Donation Child Preschool Female business Liver Failure |
| Zdroj: | American Journal of Transplantation |
| ISSN: | 1600-6143 |
| Popis: | The recent outbreak of COVID‐19 has brought elective surgeries including liver transplantation to a standstill. The concerns in Living Donor Liver Transplant (LDLT) were that immunosuppressed recipients and healthy donors would be exposed to nosocomial SARS‐ CoV‐2 infection.1 However, as patients began to suffer and die, Liver Transplant Society of India (LTSI) revised its guidelines 2 and allowed LDLT for those who were very sick, or had just recovered from a life threatening decompensation (high MELD/ CTP score) or had malignancy. Over 90 % of transplants in India are from live donors as we have a very low donation rate. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text